Advent International to acquire a significant stake in Suven Pharmaceuticals
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Ayúdame3D has become a leading social entity in social technology.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
LG Chem will receive totaling up to $95.5 million for the China rights
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Subscribe To Our Newsletter & Stay Updated